Literature DB >> 16331540

Body-mind-spirit intervention for IVF women.

Celia H Y Chan1, Cecilia L W Chan, S M Ng, Ernest H Y Ng, P C Ho.   

Abstract

BACKGROUND: Literature supports the efficacy of psychosocial intervention for infertile women. An eastern body-mind-spirit group intervention has been developed to help infertile women in the Chinese population cope with the distress arising from IVF treatment.
METHODS: The eastern body-mind-spirit group intervention adopts a bio-psycho-social-spiritual health model, recognizing the strong association between mind, body, and spirit. Chinese philosophies and concepts of health will be integrated into the intervention, helping participants to regain balance and harmony both within themselves and between them and the environment. In this paper, a revisiting of assumptions, therapeutic goals, and the therapeutic process underlying this model are outlined. Program evaluation in terms of descriptive literary sketch done by the participants will be listed so as to illustrate the clinical process.
CONCLUSIONS: It was shown and reflected that the eastern Body-Mind-Spirit approach could enhance the holistic health of IVF women. Further investigation on the program efficacy is then suggested.

Entities:  

Mesh:

Year:  2005        PMID: 16331540      PMCID: PMC3455155          DOI: 10.1007/s10815-005-6418-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  2 in total

1.  A Brief Body-Mind-Spirit Group Therapy for Chinese Medicine Stagnation Syndrome: A Randomized Controlled Trial.

Authors:  Siu-Man Ng; Lingli Leng; Rainbow T H Ho; Zhangjin Zhang; Qi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-14       Impact factor: 2.629

Review 2.  Differences in the origin of philosophy between Chinese medicine and Western medicine: Exploration of the holistic advantages of Chinese medicine.

Authors:  Da-zhi Sun; Shao-dan Li; Yi Liu; Yin Zhang; Rong Mei; Ming-hui Yang
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.